Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04467281 | A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma | withdrawn | Phase 2 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jul 1, 2022 | clinicaltrials |
| NCT00582530 | Men Undergoing Radical Prostatectomy | completed | — | 513 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT00712582 | Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma | completed | Phase 2 | 96 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT00578123 | Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy | completed | N/A | 959 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT03122496 | Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer | completed | Phase 1 | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT01591772 | Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer | completed | — | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT00416351 | Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment | completed | Phase 1 / Phase 2 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT00072358 | Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma | completed | Phase 2 | 291 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT02356575 | Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy | completed | N/A | 160 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT02429375 | Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT01463670 | Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance | completed | Phase 2 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT00581672 | Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men | completed | — | 224 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT00496613 | Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03600909 | A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia | terminated | Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT01012609 | External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas | completed | Phase 2 | 47 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Mar 14, 2022 | clinicaltrials |
| NCT02684253 | Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) | completed | Phase 2 | 65 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 10, 2022 | clinicaltrials |
| NCT01813370 | A Registry for Patients Treated on the Clinical Trial TAX 3503 | completed | — | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 3 | Mar 8, 2022 | clinicaltrials |
| NCT02027948 | A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer | completed | N/A | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT00492167 | Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT01724606 | Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) | completed | Phase 1 | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT01399918 | Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) | completed | Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT02609737 | Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors | completed | N/A | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT00550134 | Cognitive Changes Associated With Breast Cancer Treatment | completed | — | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 30, 2021 | clinicaltrials |
| NCT00590109 | Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer | completed | — | 383 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2021 | clinicaltrials |
| NCT00530049 | Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure | completed | — | 1,745 | Memorial Sloan Kettering Cancer CenterOTHER | 3 | Dec 21, 2021 | clinicaltrials |
| NCT00582335 | Identification of New Colorectal Cancer Genes | completed | — | 337 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT03166085 | PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 20, 2021 | clinicaltrials |
| NCT01811862 | Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients | completed | N/A | 63 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT02178345 | Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer | completed | — | 123 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT01131169 | Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions | completed | Phase 2 | 66 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT03430895 | Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract | completed | Phase 2 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 1, 2021 | clinicaltrials |
| NCT01404949 | Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy | completed | Phase 2 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Nov 30, 2021 | clinicaltrials |
| NCT02764333 | TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer | completed | Phase 2 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT01751451 | 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy | completed | Phase 2 | 124 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 19, 2021 | clinicaltrials |
| NCT01294670 | Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Nov 18, 2021 | clinicaltrials |
| NCT00955929 | Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy | terminated | N/A | 76 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 10, 2021 | clinicaltrials |
| NCT03012425 | Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers | completed | N/A | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | terminated | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT02282371 | Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) | completed | Phase 1 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT03096808 | Adaptive Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT01458509 | Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys | completed | — | 325 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT01157767 | Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation | completed | — | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT01558648 | Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer | completed | — | 257 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT03665155 | First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody | completed | Phase 1 / Phase 2 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT01738152 | Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health | completed | N/A | 106 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT02167854 | Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer | completed | Phase 1 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 9, 2021 | clinicaltrials |
| NCT00581750 | Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ | completed | — | 550 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2021 | clinicaltrials |
| NCT00695201 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer | completed | Phase 1 | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT02181829 | Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases | completed | Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 29, 2021 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials